Table 4:
Association Between Clinical Characteristics and Surveillance Advanced Imaging Use
| Variable | Odds Ratio (95% Confidence Interval) | P-Value |
|---|---|---|
| Age | 0.41 | |
| < 45 | 1.18 (0.84, 1.67) | |
| 45–54 | 1.27 (0.96, 1.67) | -- |
| 55–64 (Reference) | -- -- | -- |
| 65–74 | 1.18 (0.85, 1.63) | -- |
| 75+ | 1.43 (0.97, 2.11) | -- |
| Race | 0.93 | |
| White (Reference) | -- | -- |
| Non-White | 1.02 (0.71, 1.46) | -- |
| Diagnosis Year | <0.01 | |
| 2007–2012 (Reference) | -- | -- |
| 2013–2014 | 0.68 (0.52, 0.89) | -- |
| Stage | <0.01 | |
| Stage 0 | 0.55 (0.38, 0.80) | -- |
| Stage I (Reference) | -- | -- |
| Stage II | 1.85 (1.45, 2.37) | -- |
| Stage III | 3.65 (2.48, 5.38) | -- |
| ER | 0.33 | |
| Positive | 0.82 (0.54, 1.23) | -- |
| Negative (Reference) | -- | -- |
| PR | 0.36 | |
| Positive | 0.85 (0.60, 1.20) | -- |
| Negative (Reference) | -- | -- |
| HER2 | 0.96 | |
| Positive | 0.99 (0.64, 1.52) | -- |
| Negative (Reference) | -- | -- |
| Curative Therapy | 0.86 | |
| Mastectomy (Reference) | -- | -- |
| Lumpectomy + Radiation | 0.98 (0.78, 1.23) | -- |
| Family History | 0.63 | |
| Yes | 1.07 (0.82, 1.38) | -- |
| No (Reference) | -- | -- |
| Genetic Mutation | 0.46 | |
| Yes | 1.30 (0.65, 2.60) | -- |
| No (Reference) | -- | -- |
| Tumor Marker Use (Peri-diagnostic) | 0.04 | |
| Yes | 1.35 (1.01, 1.80) | -- |
| No (Reference) | -- | -- |
| Tumor Marker Use (Surveillance) | 0.19 | |
| Yes | 0.86 (0.68, 1.08) | -- |
| No (Reference) | -- | -- |
| Advanced Imaging Use (Peri-diagnostic) | <0.01 | |
| Yes | 1.76 (1.33, 2.31) | -- |
| No (Reference) | -- | -- |